These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 16565610

  • 1. [Protein expression profiles in a rat cirrhotic model induced by thioacetamide].
    An JH, Seong J, Oh H, Kim W, Han KH, Paik YH.
    Korean J Hepatol; 2006 Mar; 12(1):93-102. PubMed ID: 16565610
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.
    Bruck R, Schey R, Aeed H, Hochman A, Genina O, Pines M.
    Liver Int; 2004 Apr; 24(2):169-76. PubMed ID: 15078482
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
    Reif S, Aeed H, Shilo Y, Reich R, Kloog Y, Kweon YO, Bruck R.
    J Hepatol; 2004 Aug; 41(2):235-41. PubMed ID: 15288472
    [Abstract] [Full Text] [Related]

  • 6. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats.
    Noda S, Masumi S, Moriyama M, Kannan Y, Ohta M, Sugano T, Yamate J.
    Hepatology; 1996 Aug; 24(2):412-8. PubMed ID: 8690413
    [Abstract] [Full Text] [Related]

  • 7. A useful model to audit liver resolution from cirrhosis in rats using functional proteomics.
    Liu EH, Chen MF, Yeh TS, Ho YP, Wu RC, Chen TC, Jan YY, Pan TL.
    J Surg Res; 2007 Apr; 138(2):214-23. PubMed ID: 17292413
    [Abstract] [Full Text] [Related]

  • 8. Is anorexia in thioacetamide-induced cirrhosis related to an altered brain serotonin concentration?
    Haider S, Saleem S, Shameem S, Ahmed SP, Parveen T, Haleem DJ.
    Pol J Pharmacol; 2004 Apr; 56(1):73-8. PubMed ID: 15047980
    [Abstract] [Full Text] [Related]

  • 9. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma.
    Yeh CN, Maitra A, Lee KF, Jan YY, Chen MF.
    Carcinogenesis; 2004 Apr; 25(4):631-6. PubMed ID: 14656942
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation.
    Wang CH, Lee TH, Lu CN, Chou WY, Hung KS, Concejero AM, Jawan B.
    Gene Ther; 2006 Jul; 13(13):1000-9. PubMed ID: 16511523
    [Abstract] [Full Text] [Related]

  • 12. Altered CD38 expression in thioacetamide-induced rat model of liver cirrhosis.
    Gan BH, Ng GL, Bay BH, Chang CF.
    Liver Int; 2005 Dec; 25(6):1233-42. PubMed ID: 16343077
    [Abstract] [Full Text] [Related]

  • 13. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
    Constantinou MA, Theocharis SE, Mikros E.
    Toxicol Appl Pharmacol; 2007 Jan 01; 218(1):11-9. PubMed ID: 17113614
    [Abstract] [Full Text] [Related]

  • 14. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats.
    Cruz A, Padillo FJ, Torres E, Navarrete CM, Muñoz-Castañeda JR, Caballero FJ, Briceño J, Marchal T, Túnez I, Montilla P, Pera C, Muntané J.
    J Pineal Res; 2005 Sep 01; 39(2):143-50. PubMed ID: 16098091
    [Abstract] [Full Text] [Related]

  • 15. Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure.
    Bruck R, Oren R, Shirin H, Aeed H, Papa M, Matas Z, Zaidel L, Avni Y, Halpern Z.
    Hepatology; 1998 Apr 01; 27(4):1013-20. PubMed ID: 9537441
    [Abstract] [Full Text] [Related]

  • 16. Induced hypothyroidism accelerates the regression of liver fibrosis in rats.
    Bruck R, Weiss S, Traister A, Zvibel I, Aeed H, Halpern Z, Oren R.
    J Gastroenterol Hepatol; 2007 Dec 01; 22(12):2189-94. PubMed ID: 18031379
    [Abstract] [Full Text] [Related]

  • 17. High voluntary alcohol consumption, in experimental liver cirrhosis is hardly responsive to opioid antagonist treatment.
    Stasiak A, Fogel WA.
    J Physiol Pharmacol; 2008 Mar 01; 59(1):101-14. PubMed ID: 18441391
    [Abstract] [Full Text] [Related]

  • 18. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis.
    Neef M, Ledermann M, Saegesser H, Schneider V, Reichen J.
    J Hepatol; 2006 Dec 01; 45(6):786-96. PubMed ID: 17050028
    [Abstract] [Full Text] [Related]

  • 19. Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1.
    Kornek M, Raskopf E, Guetgemann I, Ocker M, Gerceker S, Gonzalez-Carmona MA, Rabe C, Sauerbruch T, Schmitz V.
    J Hepatol; 2006 Sep 01; 45(3):370-6. PubMed ID: 16780996
    [Abstract] [Full Text] [Related]

  • 20. Resistance of erythrocytes to lipid peroxidation in cirrhotic rats.
    Oztezcan S, Balkan J, Dogru-Abbasoglu S, Cevikbas U, Aykaç-Toker G, Uysal M.
    Arch Med Res; 2005 Sep 01; 36(5):459-63. PubMed ID: 16099321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.